AC Immune (ACIU) EBITDA Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | 63,503.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,503.00 |
| Dec 31, 2025 | -262,111.00 |
| Sep 30, 2025 | -175,014.00 |
| Jun 30, 2025 | 156,656.00 |
| Dec 31, 2020 | 12,675.00 |
| Sep 30, 2020 | -249,167.00 |
| Jun 30, 2020 | -47,071.00 |
| Mar 31, 2020 | -13,962.00 |
| Dec 31, 2019 | -89,630.00 |
| Sep 30, 2019 | 134,516.00 |
| Jun 30, 2019 | -40,725.00 |
| Mar 31, 2019 | 85,671.00 |
| Dec 31, 2018 | -137,825.00 |
| Sep 30, 2018 | 115,077.00 |
| Jun 30, 2018 | 76,674.00 |
| Mar 31, 2018 | -38,601.00 |
| Dec 31, 2017 | -81,126.00 |
| Sep 30, 2017 | -105,757.00 |
| Mar 31, 2017 | 79,715.00 |
| Dec 31, 2016 | 189,002.00 |
| Sep 30, 2016 | -70,053.00 |